| 1 |
Rebecca L, Kimberly D, Ahmedin Jemal, et al. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1):7-34.
|
| 2 |
张盛苗，张萍，陈龙. 腹腔镜在卵巢癌治疗中的应用价值[J]. 中国实用妇科与产科杂志，2017, 33(5):530-533.
|
| 3 |
Ghirardi V, Moruzzi MC, Bizzarri N，et al. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: a survival analysis[J]. Gynecol Oncol, 2019, 14(1):1-5.
|
| 4 |
Sioulas VD, Schiavone MB, Kadouri D, et al. Optimal primary management of bulky stageⅢC ovarian, fallopian tube and peritoneal carcinoma：are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy[J]. Gynecol Oncol, 2017, 145(1):15-20.
|
| 5 |
Auer RC, Sivajohanathan D, Biagi J，et al. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review[J]. Eur J Cancer, 2020, 27(3):76-95.
|
| 6 |
刘传忠，王鹤，蔡志福，等. 晚期上皮性卵巢癌不同治疗方案的预后影响因素分析[J]．肿瘤防治研究，2018，45(10):746-751.
|
| 7 |
Stephanie L, Charlie G, Ignace V, et al. Epithelial ovarian cancer[J]. Lancet (London, England), 2019, 393(10177):1240-1253.
|
| 8 |
Feng LY, Liao SB, Li L. Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer：a preliminary model study[J]. J Ovarian Res, 2020, 13(1):17-25.
|
| 9 |
蒋清秀，令狐华. HE4对晚期卵巢癌患者初次肿瘤细胞减灭术结局的预测价值[J/CD]. 实用妇科内分泌电子杂志，2019, 6(11):5-7.
|
| 10 |
Hu TWY, Nie D, Gou JH, et al. Predictive significance of preoperative CT fingdings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis[J]. Caner Manag Res, 2018，16(10):2019-2030.
|
| 11 |
Suidan RS, Ramirez PT, Sarasohn DM, et al. Amulticenter prospective trial evaluating the ability of preoperativ e computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer[J]. Gynecol Oncol, 2014, 134 (3):455-461.
|
| 12 |
Bogani G, Cromi A, Serati M, et al. Laparoscopic and open abdominal staging for early-stage ovarian cancer：our experience, systematic review, and meta-analysis of comparative studies[J]. Int J Gynecol Cancer, 2014, 24(7):1241-1249.
|
| 13 |
Lee M, Kim SW, Paek J, et al. Comparisons of surgical outcomes, complications, and costs between laparotomy and laparoscopy in early-stage ovarian cancer[J]. Int J Gynecol Cancer, 2011, 21(2):251-256.
|
| 14 |
Fagotti A, Fanfani F, Ludovisi M, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer：a pilot study[J]. Gynecol Oncol, 2005, 96(3):729-735.
|
| 15 |
Fagotti A, Ferrandina G, Fanfani F，et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma：a pilot study[J]. Ann Surg Oncol, 2006, 13(8):1156-1161.
|
| 16 |
Fagotti A, Ferrandina G, Fanfani F, et al.Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma[J]. Am J Obstet Gynecol, 2008, 199(6):642-648.
|
| 17 |
Fagotti A, Fanfani F, Vizzielli G, et al. Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery [J]．Gynecol Oncol, 2010, 116(1):72-77.
|
| 18 |
Fagotti A, Vizzielli G, Fanfani F, et al. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience[J]．Gynecol Oncol, 2013, 131(2):341-346.
|
| 19 |
Petrillo M, Vizzielli G, Fanfani F, et al.Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept[J]．Gynecol Oncol, 2015, 139(1):5-9.
|
| 20 |
吴科，王亚，唐郢，等. 腹腔镜预测指数与晚期卵巢癌患者一期切除结果的一致性及预测价值[J]. 腹腔镜外科杂志，2020，25(2):150-153.
|
| 21 |
Zeff N. Role of laparoscopy in initial tumour staging in advanced epithelial ovarian cancer：a systematic review[J]. Pleura Peritoneum, 2018, 3(1):20180106. DOI：
10.1515/pp-2018-0106
|
| 22 |
Ataseven B, Grimm C, Harter P, et al. Prognostic impact of port-site metastasis after diagnostic laparoscopy for pithelial ovarian cancer[J]. Ann Surg Oncol, 2016, 23 (5):834-840.
|
| 23 |
张师前，董延磊．腹腔镜在卵巢癌诊治中需要重视的问题商榷[J/CD]．中华腔镜外科杂志(电子版), 2018, 11(2):77-79.
|
| 24 |
孙大为．正确认识单孔腹腔镜手术在妇科的应用[J/CD]．中华腔镜外科杂志(电子版)，2012，5(4):260-262.
|
| 25 |
刘青，关小明．单孔腹腔镜在妇科中的应用现状及发展[J]. 实用妇产科杂志，2019, 35(3):161-163.
|
| 26 |
Fagotti A, Scambia G, Fanfani F, et al. First 100 early endometrial cancer cases treated with laparoendoscopic single-site surgery: a multicentric retrospective study[J]. Am J Obstet Gynecol，2012，206(4):1-6.
|
| 27 |
王延洲，陈功立，徐嘉莉，等. 单孔腹腔镜广泛子宫切除盆腔淋巴结清扫治疗宫颈癌：一项单中心的初步研究[J]．第三军医大学学报，2017，39(13):1392-1395.
|
| 28 |
王延洲，邓黎，梁志清. 单孔腹腔镜技术在妇科恶性肿瘤中的应用[J/CD]. 妇产与遗传(电子版)，2019，9(2):46-48.
|
| 29 |
龙宇，唐岸柳，田力，等. 经脐内镜手术在不明原因腹水诊断中的应用[J]. 中南大学学报(医学版), 2019, 44(6):634-641.
|
| 30 |
Li SL, Zhao E, Zhao L, et al. Natural orifice transluminal endoscopic surgery in the diagnosis of ascites of unknown origin[J]. Gastrointest Endosc, 2019, 89(4):872-877.
|
| 31 |
Fu T, Liu Y, Li K. Hybrid transvaginal natural orifice transluminal endoscopic surgery of radical sigmoidectomy for sigmiod colon cancer[J]. Surg Oncol, 2019, 30(9):90-91.
|
| 32 |
张魁，梁海霞，周建兴. 单孔腹腔镜手术探查并诊治子宫切除术后盆腔包块53例临床分析[J]．腹腔镜外科杂志，2012，17(7):538-540.
|
| 33 |
王延洲．单孔腹腔镜技术在妇科恶性肿瘤中的应用体会[J]．山东大学学报(医学版), 2019, 57(12):15-18.
|
| 34 |
Moulton IJ, Jernigan AM, Michener CM. Postoperative outcomes after single-port laparoscopic removal of adnexal masses in patients referred to gynecologic oncology at a large academic center[J]. J Minim Invasive Gynecol, 2017，24(7):1136-1144.
|
| 35 |
Yoo JG, Kim WJ, Lee KH. Single-site robot-assisted laparoscopic staging surgery for presumed clinically early-stage ovarian cancer[J]. J Minim Invasive Gynecol, 2018, 25(3):380-381.
|
| 36 |
綦小蓉，陈思敬，郑莹. 单孔腹腔镜在妇科恶性肿瘤治疗中的利与弊[J/CD]. 中华腔镜外科杂志(电子版)，2018，11(6):370-373.
|
| 37 |
邓黎，梁志清．单孔腹腔镜技术在妇科恶性肿瘤中的应用[J]．实用妇产科杂志，2019，35(3):164-166.
|